National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample

Citation
Mr. Frankel et al., National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample, HEAL SERV R, 34(5), 1999, pp. 969-992
Citations number
7
Categorie Soggetti
Public Health & Health Care Science","Health Care Sciences & Services
Journal title
HEALTH SERVICES RESEARCH
ISSN journal
00179124 → ACNP
Volume
34
Issue
5
Year of publication
1999
Part
1
Pages
969 - 992
Database
ISI
SICI code
0017-9124(199912)34:5<969:NPSISO>2.0.ZU;2-7
Abstract
Objective. The design and implementation of a nationally representative pro bability sample of persons with a low-prevalence disease, HIV/AIDS. Data Sources/Study Setting. One of the most significant roadblocks to the g eneralizability of primary data collected about persons with a low-prevalen ce disease is the lack of a complete methodology for efficiently generating and enrolling probability samples. The methodology developed by the HCSUS consortium uses a flexible, provider-based approach to multistage sampling that minimizes the quantity of data necessary for implementation. Study Design. To produce a valid national probability sample, we combined a provider-based multistage design with the M.D.-colleague recruitment model often used in non-probability site-specific studies. Data Collection. Across the contiguous United States, reported AIDS cases f or metropolitan areas and rural counties. In selected areas, caseloads for known providers for HIV patients and a random sample of other providers. Fo r selected providers, anonymous patient visit records. Principal Findings. It was possible to obtain all data necessary to impleme nt a multistage design for sampling individual HIV-infected persons under m edical care with known probabilities. Taking account of both patient and pr ovider nonresponse, we succeeded in obtaining in-person or proxy interviews from subjects representing over 70 percent of the eligible target populati on. Conclusions. It is possible to design and implement a national probability sample of persons with a low-prevalence disease, even if it is stigmatized.